MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
2014 · Nature · 525 citations
https://doi.org/10.1038/nature13181
R
Roger Olofsson Bagge
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
409
Papers
5.2K
Citations
35
h-index
96
i10-index
Roger Olofsson Bagge is an academic researcher from Sahlgrenska University Hospital. The author has contributed to research in topics: Immunotherapy and Immune Responses & Cutaneous Melanoma Detection and Management & Ocular Oncology and Treatments. The author has an h-index of 35, co-authored 348 publications.
ORCID: 0000-0001-5795-0355Papers by this author
worksAdvances in the clinical management of uveal melanoma
2023 · Nature Reviews Clinical Oncology · 242 citations
https://doi.org/10.1038/s41571-022-00714-1
ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee
2020 · Annals of Oncology · 229 citations
https://doi.org/10.1016/j.annonc.2020.07.004
Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases
2024 · New England Journal of Medicine · 221 citations
https://doi.org/10.1056/nejmoa2313487
Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial
2017 · BMC Cancer · 174 citations
https://doi.org/10.1186/s12885-017-3361-y
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
2021 · Nature Communications · 170 citations
https://doi.org/10.1038/s41467-021-25332-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat